Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01588535 · ClinicalTrials.gov registry record · Phase 2
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
A Phase 2 study of Pain and Otitis Media, sponsored by Arbor Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
- 15
- Study locations
NCT01588535: Completed Phase 2 study of Pain and Otitis Media, sponsored by Arbor Pharmaceuticals.
NCT01588535 is a Phase 2 study of Pain and Otitis Media that has completed, run by Arbor Pharmaceuticals. The registered enrollment target is 38 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (87% lower). The trial reports 15 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01588535, a Phase 2 study of Pain and Otitis Media, has completed, sponsored by Arbor Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
- 15
- Study locations
Study Summary
This study is to assess the reliability and validity of the FAECC scale to evaluate pain associated with acute otitis media in children aged 2 months to 5 years.
Conditions Studied
Interventions
- DRUG placebo
- DRUG benzocaine
Study Locations (15)
Texas
- DiscoveReseach, Inc. - Bryan
- Research Across America - Carrollton
- Research Across America - Dallas
- Dm Clinical Research - Tomball
Utah
- Foothill Family Clinic - Salt Lake City
- FIRSTMED - Salt Lake City
- Jordon River Family Medicine - South Jordan
Arkansas
- Nda Baptist Clinic - Jonesboro
Florida
- COMMUNITY Medical Research - Miami Beach
Iowa
- The Iowa Clinic, Pc - West Des Moines
Kentucky
- Kentucky Pediatric/Adult Research - Bardstown
Nebraska
- Prairie Fields Family Medicine/Clinical Research Advantage - Fremont
Nevada
- Clinical Research Center - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
What the finished NCT01588535 record still lists
NCT01588535 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT01588535 lists 15 locations in 10 states (Texas, Utah, Arkansas).
Frequently Asked Questions
What is clinical trial NCT01588535 about?
NCT01588535 is a clinical study titled "Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media". This study is to assess the reliability and validity of the FAECC scale to evaluate pain associated with acute otitis media in children aged 2 months to 5 years.
What is the current status of trial NCT01588535?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2012-05. Estimated completion is 2012-08.
What conditions does trial NCT01588535 study?
This clinical trial studies the following conditions: Pain, Otitis Media.
What interventions are being tested in trial NCT01588535?
The interventions under investigation include: placebo (DRUG), benzocaine (DRUG).
Who is sponsoring clinical trial NCT01588535?
This trial is sponsored by Arbor Pharmaceuticals, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01588535 being conducted?
This trial has 15 study locations across Arkansas, Florida, Iowa, Kentucky, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01588535's enrollment target sits among peer trials
38 293rd of 374 higher than 81 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Neural Correlates of Hypoalgesia Driven by Observation
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Pain After Buffered Vs Non Buffered Articaine
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia